FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 72 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $16,000 | +220.0% | 4,751 | +196.0% | 0.00% | – |
| Q3 2019 | $5,000 | +66.7% | 1,605 | +26.9% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 1,265 | +53.7% | 0.00% | – |
| Q1 2019 | $3,000 | -40.0% | 823 | -21.9% | 0.00% | – |
| Q1 2017 | $5,000 | -86.5% | 1,054 | -68.2% | 0.00% | – |
| Q4 2016 | $37,000 | -33.9% | 3,312 | -44.8% | 0.00% | – |
| Q3 2016 | $56,000 | +55.6% | 6,000 | +6.1% | 0.00% | – |
| Q2 2016 | $36,000 | -77.5% | 5,656 | -76.9% | 0.00% | – |
| Q1 2016 | $160,000 | +77.8% | 24,474 | +121.1% | 0.00% | – |
| Q4 2015 | $90,000 | – | 11,070 | +276650.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 4 | -99.9% | 0.00% | – |
| Q2 2015 | $32,000 | – | 3,161 | +4998.4% | 0.00% | – |
| Q4 2014 | $0 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |